Literature DB >> 15951314

Association between hydrogen peroxide-dependent byproducts of ascorbic acid and increased hepatic acetyl-CoA carboxylase activity.

Laurent Knafo1, Philippe Chessex, Thérèse Rouleau, Jean-Claude Lavoie.   

Abstract

BACKGROUND: Parenteral multivitamin preparation (MVP) induces fatty liver in neonatal guinea pig pups; this is prevented by photoprotection. Photo-excited riboflavin present in MVP generates H(2)O(2) and molecules with masses of 136 and 208. We hypothesized that H(2)O(2) initiates the peroxidation of ascorbic acid (AA), producing biologically active byproducts affecting hepatic lipid metabolism.
METHODS: Mass spectrometry (MS) documented the participation of H(2)O(2) and photo-excited riboflavin (Ribo) in the formation of AA byproducts. Sixteen 3-day-old guinea pig pups received an intravenous solution (50 g/L dextrose + 4.5 g/L NaCl + 1 kIU/L heparin) at 240 mL x kg(-1) x day(-1), enriched with control or test mixtures, for 4 days. The control mixture was photo-protected AA + Ribo (without byproducts or H(2)O(2)), and the test mixture was AA + Ribo treated to generate AA byproducts without H(2)O(2). Hepatic acetyl-CoA carboxylase (ACC) activity was determined after 4 days. Fourth-day urine samples were analyzed by MS. Data were treated by ANOVA (alpha = 0.05).
RESULTS: H(2)O(2) did not influence the classic degradation of AA, as the generation of 2,3-diketogulonic acid was not affected. In contrast, the formation of molecules with masses of 136 and 208 was H(2)O(2) and time dependent. ACC activity was higher (P <0.01) in animals receiving high concentration of these molecules; its hepatic activation correlated (P <0.01) with the urinary concentration of molecule-208.
CONCLUSIONS: H(2)O(2) at concentrations found in the clinical setting of total parenteral nutrition induce the transformation of dehydroascorbic acid into compounds that have the potential to affect lipid metabolism. These molecules have peroxide and aldehyde functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15951314     DOI: 10.1373/clinchem.2005.050427

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Effects of light exposure on total parenteral nutrition and its implications in the neonatal population.

Authors:  David S Hoff; Amanda S Michaelson
Journal:  J Pediatr Pharmacol Ther       Date:  2009-07

2.  Inflammatory response in preterm infants is induced early in life by oxygen and modulated by total parenteral nutrition.

Authors:  Pascal M Lavoie; Jean-Claude Lavoie; Carla Watson; Thérèse Rouleau; Brent A Chang; Philippe Chessex
Journal:  Pediatr Res       Date:  2010-09       Impact factor: 3.756

Review 3.  Mechanism of action of vitamin C in sepsis: ascorbate modulates redox signaling in endothelium.

Authors:  John X Wilson
Journal:  Biofactors       Date:  2009 Jan-Feb       Impact factor: 6.113

4.  Relationship between redox potential of glutathione and DNA methylation level in liver of newborn guinea pigs.

Authors:  Angela Mungala Lengo; Clémence Guiraut; Ibrahim Mohamed; Jean-Claude Lavoie
Journal:  Epigenetics       Date:  2020-06-28       Impact factor: 4.528

5.  Metabolomic markers for intestinal ischemia in a mouse model.

Authors:  René Fahrner; Diren Beyoğlu; Guido Beldi; Jeffrey R Idle
Journal:  J Surg Res       Date:  2012-08-25       Impact factor: 2.192

6.  Pharmacometabolomic signature of ataxia SCA1 mouse model and lithium effects.

Authors:  Bertrand Perroud; Paymaan Jafar-Nejad; William R Wikoff; Jennifer R Gatchel; Lu Wang; Dinesh K Barupal; Juan Crespo-Barreto; Oliver Fiehn; Huda Y Zoghbi; Rima Kaddurah-Daouk
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

7.  Ascorbylperoxide from parenteral nutrition induces an increase of redox potential of glutathione and loss of alveoli in newborn guinea pig lungs.

Authors:  Wesam Elremaly; Ibrahim Mohamed; Tiphaine Mialet-Marty; Thérèse Rouleau; Jean-Claude Lavoie
Journal:  Redox Biol       Date:  2014-05-20       Impact factor: 11.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.